Aquestive Therapeutics (AQST) Amortizatization of Intangibles (2017 - 2019)
Aquestive Therapeutics (AQST) posted quarterly Amortizatization of Intangibles of $36000.0 for Q3 2019, up 9.09% year-over-year from $33000.0 in Q3 2018, and little changed quarter-over-quarter from $36000.0 in Q2 2019.
Aquestive Therapeutics (AQST) Amortizatization of Intangibles (2017 - 2019) Analysis & Trends
Aquestive Therapeutics' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $36000.0 for Q3 2019.
- In Q3 2019, Amortizatization of Intangibles rose 9.09% year-over-year to $36000.0; the TTM figure through Sep 2019 stood at $134000.0 (changed 0.0% YoY), while the FY2018 annual figure was $130000.0, up 6.56% from the prior year.
- Amortizatization of Intangibles for Q3 2019 stood at $36000.0, roughly flat from $36000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $36000.0 in Q2 2019, with the low at $28000.0 in Q4 2018.
- The 3-year median for Amortizatization of Intangibles is $34000.0 (2018), against an average of $33222.2.
- The sharpest annual moves came in 2018 and 2019: Amortizatization of Intangibles slipped 12.5% in 2018, then climbed 9.09% in 2019.
- Aquestive Therapeutics' Amortizatization of Intangibles stood at $32000.0 in 2017, then retreated by 12.5% to $28000.0 in 2018, then gained by 28.57% to $36000.0 in 2019.
- Business Quant data shows AQST's Amortizatization of Intangibles at $36000.0 in Q3 2019, $36000.0 in Q2 2019, and $34000.0 in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Aquestive Therapeutics | 560.60 Mn | 560.60 Mn | 9.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 36,000.00 |
| Sep 30, 2019 | 36,000.00 |
| Jun 30, 2019 | 36,000.00 |
| Jun 30, 2019 | 36,000.00 |
| Mar 31, 2019 | 34,000.00 |
| Mar 31, 2019 | 34,000.00 |
| Dec 31, 2018 | 28,000.00 |
| Dec 31, 2018 | 28,000.00 |
| Sep 30, 2018 | 33,000.00 |
| Sep 30, 2018 | 33,000.00 |
| Jun 30, 2018 | 35,000.00 |
| Jun 30, 2018 | 35,000.00 |
| Mar 31, 2018 | 34,000.00 |
| Mar 31, 2018 | 34,000.00 |
| Dec 31, 2017 | 32,000.00 |
| Dec 31, 2017 | 32,000.00 |
| Sep 30, 2017 | 31,000.00 |
| Sep 30, 2017 | 31,000.00 |